Related Experiment Videos
The rationale for immunotherapy in respiratory allergies
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Allergic Rhinitis and Sinusitis.
Postgraduate medicine·2016
Insect sting allergy with negative venom skin test responses.
The Journal of allergy and clinical immunology·2001
The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.
The Journal of allergy and clinical immunology·1998
Effects of peptide therapy on ex vivo T-cell responses.
The Journal of allergy and clinical immunology·1998
A double-blind study of the discontinuation of ragweed immunotherapy.
The Journal of allergy and clinical immunology·1997
Clinical and immunologic effects of component peptides in Allervax Cat.
International archives of allergy and immunology·1997
HEALTHY AGING: THE PROMISE, AND PERILS, OF GEROSCIENCE.
Transactions of the American Clinical and Climatological Association·2025
TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.
Transactions of the American Clinical and Climatological Association·2025
REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?
Transactions of the American Clinical and Climatological Association·2025
IMPLEMENTING HOME-BASED CANCER PREVENTION AND SCREENING: AN OPPORTUNITY FOR EQUITY.
Transactions of the American Clinical and Climatological Association·2025
THE GID COMPLEX REGULATES DNA END PROCESSING DURING DNA DOUBLE-STRAND BREAK REPAIR BY NONHOMOLOGOUS END JOINING.
Transactions of the American Clinical and Climatological Association·2025
THERAPIES FOR NEONATAL DISEASES OF THE SURFACTANT SYSTEM.
Transactions of the American Clinical and Climatological Association·2025
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026